FSGS
First Trust SMID Growth Strength ETF
First Trust SMID Growth Strength ETF seeks to provide investors with long-term capital appreciation by investing primarily in growth-oriented small and mid-cap companies.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 29.0 M
ASSETS UNDER MGMT
60 bp
EXPENSES
Fund Basics
| Inception date | Jun 20, 2017 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| STERLING CONSTRUCTION CO | 1.9 % |
| MYR GROUP INC/DELAWARE | 1.5 % |
| INTEGRATED ELECTRICAL SERVIC | 1.3 % |
| PROGYNY, INC. | 1.3 % |
| POWELL INDUSTRIES INC | 1.3 % |
| CATALYST PHARMACEUTICAL PART | 1.2 % |
| NEUROCRINE BIOSCIENCES INC | 1.2 % |
| SPROUTS FARMERS MARKET INC | 1.2 % |
| BLUE BIRD CORPORATION | 1.2 % |
| EMCOR GROUP INC | 1.2 % |
Constituent Breakdown
| Number of holdings | 101 |
| Herfindahl-Hirschman Index | 102 |
| Wgt avg mkt cap (mns) | $9,219 |
| Large cap (>$10bn) | 36.4% |
| Mid cap ($2-10bn) | 52.9% |
| Small cap (<$2bn) | 9.6% |
| Developed mkts. | 98.9% |
| Emerging mkts. | 0.9% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 97.1 % |
 |
IRELAND | 1.9 % |
 |
BERMUDA | 1.0 % |
Historical Performance
Standardized Performance (as of 04/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 0.7% | 11.5% | 6.4% | 5.7% | 1.2% | -- | -- | 5.0% |
| Dividend Yield | 0.0% | 0.0% | 1.4% | 1.7% | 1.7% | -- | -- | 1.8% |
| Total Returns | 0.7% | 11.5% | 7.7% | 7.4% | 2.9% | -- | -- | 6.8% | Ann. Volatility | 17.0% | 15.8% | 19.5% | 19.3% | 20.2% | -- | -- | 22.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.00 | 62% |
| MSCI EAFE | 0.68 | 39% |
| MSCI Emg Mkts | 0.47 | 30% |
Liquidity Measures
| Avg. volume (000) | 1 |
| ADV traded (mns) | $0 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.40% |
Technical Indicators
| 30d moving avg. (EMA) | $30.54 |
| Relative strength (RSI) | 48 |
| MACD/Signal | 0.04/0.15 |
| Bollinger Bands (Upper/Lower) | $31.38/$30.18 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. FSGS |
Expenses vs. FSGS |
ALTAR Score™ vs. FSGS |
|---|---|---|---|---|
| RNSC | Furst Trust Small Cap US Equity Select ETF | 92.2% | 0 bp | -0.5% |
| FSCS | First Trust SMID Capital Strength ETF | 22.6% | 0 bp | +1.9% |
| RFG | Invesco S&P Midcap 400 Pure Growth ETF | 21.3% | -25 bp | -0.6% |
| RNMC | First Trust Mid Cap US Equity Select ETF | 21.0% | 0 bp | +1.4% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 20.3% | -43 bp | -1.3% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 20.0% | -45 bp | -1.3% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 20.0% | -50 bp | -1.3% |
| SDVY | First Trust SMID Cap Rising Dividend Achievers ETF | 19.8% | 0 bp | +0.7% |
| GRPZ | Invesco S&P SmallCap 600 GARP ETF | 19.5% | -25 bp | +1.4% |
| MCOW | Pacer S&P MidCap 400 Quality FCF Aristocrats ETF | 19.3% | -11 bp | +1.3% |
Risk and Returns: FSGS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 5/19/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.2%
ALTAR SCORE™
64th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,304 funds in the US Equity category with an average
ALTAR Score™ of 5.4% and a standard deviation
of 2.1%. FSGS's ALTAR Score™ is approximately 0.4 standard
deviations above the category average. This places FSGS in the 64th percentile
among funds in the category.
Sell-Side Consensus
$38.16
PRICE TARGET
+25.1%
UPSIDE